SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

--UBS Adjusts Price Target on Vertex Pharmaceuticals to $279 From $278, Maintains Buy Rating

05/12/2021 06:01

09:55 AM EDT, 05/12/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 214.09, Change: +1.09, Percent Change: +0.51